Overall rank by patents
#2,373
Across all tracked assignees
USPTO PatentsView assignee record - 165 granted patents across 15 technology areas, active 2018–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA).
The verdict
Inscripta holds 165 US patents across 15 technology areas, rank #2,373 of 50,000 tracked assignees.
Inscripta Inc. has been granted 165 US utility patents between 2018 and 2025, placing Inscripta Inc. at rank #2,373 across all assignees tracked by PlainPatent. This portfolio spans 15 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.6 claims per patent with primary concentration in C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA). As a US Corporation, Inscripta Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Inscripta sits between Amdocs Software Systems Limited (165 patents, rank #2,369) and Amogreentech Co., Ltd. (164 patents, rank #2,377) - the closest US assignees by grant volume. The composite Innovation Score of 46.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 139 grants, compared with 26 in the 2015–2019 window, a +435% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Inscripta Inc.'s 19.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 15 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Inscripta Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
AMDOCS SOFTWARE SYSTEMS LIMITED
165 patents
DMG MORI CO., LTD.
165 patents
Godo Kaisha IP Bridge 1
165 patents
HORIBA STEC, CO., LTD.
165 patents
MESO SCALE TECHNOLOGIES, LLC.
165 patents
PING AN TECHNOLOGY (SHENZHEN) CO., LTD.
165 patents
SOLiD, INC.
165 patents
Inscripta Inc.
165 patents
AMOGREENTECH CO., LTD.
164 patents
What this shows Inscripta holds 165 patents at rank #2,373, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #2,373 in granted patent volume.
Other assignees with the most granted patents in Inscripta's primary technology class.
Inscripta's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
46 Top 22% higher than 78% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 3 | 1.8% |
| 2019 | 23 | 13.9% |
| 2020 | 52 | 31.5% |
| 2021 | 35 | 21.2% |
| 2022 | 28 | 17.0% |
| 2023 | 15 | 9.1% |
| 2024 | 6 | 3.6% |
| 2025 | 3 | 1.8% |
Top 15 of 15 technology areas
Overall rank by patents
#2,373
Across all tracked assignees
46.1 out of 100
How to use this portfolio
Inscripta's 165 grants land it in the top 22% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.